{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:30:03Z","timestamp":1793658603681,"version":"4.5.1"},"reference-count":121,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Small-scale clinical studies with psychedelic drugs have shown promising results for the treatment of several mental disorders. Before psychedelics become registered medicines, it is important to know the full range of adverse events (AEs) for making balanced treatment decisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To systematically review the presence of AEs during and after administration of serotonergic psychedelics and 3,4-methyenedioxymethamphetamine (MDMA) in clinical studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We systematically searched PubMed, PsycINFO, Embase, and ClinicalTrials.gov for clinical trials with psychedelics since 2000 describing the results of quantitative and qualitative studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>We included 44 articles (34 quantitative\u2009+\u200910 qualitative), describing treatments with MDMA and serotonergic psychedelics (psilocybin, lysergic acid diethylamide, and ayahuasca) in 598 unique patients. In many studies, AEs were not systematically assessed. Despite this limitation, treatments seemed to be overall well tolerated. Nausea, headaches, and anxiety were commonly reported acute AEs across diagnoses and compounds. Late AEs included headaches (psilocybin, MDMA), fatigue, low mood, and anxiety (MDMA). One serious AE occurred during MDMA administration (increase in premature ventricular contractions requiring brief hospitalization); no other AEs required medical intervention. Qualitative studies suggested that psychologically challenging experiences may also be therapeutically beneficial. Except for ayahuasca, a large proportion of patients had prior experience with psychedelic drugs before entering studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>AEs are poorly defined in the context of psychedelic treatments and are probably underreported in the literature due to study design (lack of systematic assessment of AEs) and sample selection. Acute challenging experiences may be therapeutically meaningful, but a better understanding of AEs in the context of psychedelic treatments requires systematic and detailed reporting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811221116926","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T05:54:07Z","timestamp":1661493247000},"page":"1100-1117","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":159,"title":["Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review"],"prefix":"10.1177","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8787-4610","authenticated-orcid":false,"given":"Joost J","family":"Breeksema","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"},{"name":"Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"OPEN Foundation, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouwe W","family":"Kuin","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine","family":"Kamphuis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"van den Brink","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Amsterdam University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0579-4404","authenticated-orcid":false,"given":"Eric","family":"Vermetten","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Schoevers","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.1c00014"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06123-7"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13249"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100538"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-021-03663-8"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881115626348"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109735"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2019.1580805"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116678781"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.paid.2017.06.004"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/0022167817706884"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114565144"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00100"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120926673"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2008.10400637"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-020-00748-y"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.1c00149"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116662634"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032994"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4771-x"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30065-7"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1159\/000447034"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-017-0633-z"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-196001000-00005"},{"key":"e_1_3_3_26_1","unstructured":"Compass Pathways (2021) COMP360 psilocybin therapy for treatment-resistant depression. Phase Iib topline data. Available at: https:\/\/j8g9v7z6.rocketcdn.me\/wp-content\/uploads\/2021\/11\/COMP001_-_topline_data.pdf (accessed 9 November 2021)."},{"key":"e_1_3_3_27_1","unstructured":"Critical Appraisal Skills Programme (2020) CASP qualitative checklist. Available at: https:\/\/casp-uk.net\/casp-tools-checklists\/ (accessed 30 July 2021)."},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-018-5010-9"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.3285"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4650-5"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116652578"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2018.1511424"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001428"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881106063271"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1590\/1516-4446-2020-0913"},{"key":"e_1_3_3_36_1","first-page":"3","article-title":"Lessons to be learned from early psychedelic therapy in Denmark","volume":"9488","author":"Erritzoe D","year":"2017","unstructured":"Erritzoe D, Richards WA (2017) Lessons to be learned from early psychedelic therapy in Denmark. Nord J Psychiatry 9488: 3\u20135.","journal-title":"Nord J Psychiatry"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2019.112532"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000084"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102997"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/NMD.0000000000000113"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114555249"},{"key":"e_1_3_3_42_1","doi-asserted-by":"crossref","unstructured":"Golder S Loke YK Wright K et al. (2016) Reporting of adverse events in published and unpublished studies of health care interventions: A systematic review. PLoS Med 13: 1\u201322.","DOI":"10.1371\/journal.pmed.1002127"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2019.05.019"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675513"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0457-5"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.116"},{"key":"e_1_3_3_47_1","volume-title":"LSD Psychotherapy: Exploring the Frontiers of the Hidden Mind","author":"Grof S","year":"2001","unstructured":"Grof S (2001) LSD Psychotherapy: Exploring the Frontiers of the Hidden Mind, 3rd edn. Sarasota, FL: Multidisciplinary Association for Psychedelic Studies.","edition":"3"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2013.763564"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.2.188"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.3.409"},{"key":"e_1_3_3_51_1","first-page":"333","volume-title":"Behavioral Neurobiology of Psychedelic Drugs","author":"Halpern JH","year":"2018","unstructured":"Halpern JH, Lerner AG, Passie T (2018) A review of hallucinogen persisting perception disorder (HPPD) and an exploratory study of subjects claiming symptoms of HPPD. In: Halberstadt AL, Nichols DE, Vollenweider FX (eds) Behavioral Neurobiology of Psychedelic Drugs. Berlin: Springer Verlag GmbH Germany, pp. 333\u2013360."},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(02)00306-X"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X16666180125095902"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00129"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1590\/1516-4446-2020-0980"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108093587"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.10.029"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114548296"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-018-4886-8"},{"key":"e_1_3_3_60_1","article-title":"The acute effects of MDMA in social contexts","volume":"39","author":"Kirkpatrick M","year":"2014","unstructured":"Kirkpatrick M, De Wit H (2014) The acute effects of MDMA in social contexts. Neuropsychopharmacology 39: S466.","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000648"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(00)00126-3"},{"key":"e_1_3_3_63_1","unstructured":"Lindsay B (2022) Health Canada announces review of all MDMA trials as complaint alleges major flaws and safety issues. CBC News. Available at: https:\/\/www.cbc.ca\/news\/canada\/british-columbia\/health-canada-mdma-trial-complaints-flaws-safety-issues-1.6409849 (accessed 8 April 2022)."},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2014.05.008"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-7-32"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00256"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-018-1824-6"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01336-3"},{"key":"e_1_3_3_69_1","volume-title":"A Manual for MDMA-Assisted Psychotherapy in the Treatment of Posttraumatic Stress Disorder","author":"Mithoefer MC","year":"2013","unstructured":"Mithoefer MC, Doblin R, Mithoefer A, et al. (2013a) A Manual for MDMA-Assisted Psychotherapy in the Treatment of Posttraumatic Stress Disorder. Santa Cruz, CA: MAPS."},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-019-05249-5"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30135-4"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110378371"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112456611"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.06.005"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1080\/20008198.2020.1840123"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n1110"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06066-z"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.573953"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1933434"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.852248"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00132"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000123."},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118780612"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112464827"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-021-05964-y"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1093\/jhmas\/jrs050"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1177\/0957154X16648822"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1590\/1516-4446-2014-1496"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118806297"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291718001356"},{"key":"e_1_3_3_91_1","unstructured":"Peryer G Golder S Junqueira D et al. (2021) Chapter 19: Adverse effects. In: Higgins JPT Thomas J Chandler J et al. (eds) Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (Updated February 2021). Cochrane. Available at: http:\/\/www.training.cochrane.org\/handbook (accessed 21 March 2022)."},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1177\/0022167817711304"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.5040\/9798400607196.ch-014"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.19010035"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119855974"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00974"},{"key":"e_1_3_3_97_1","unstructured":"Rosin H (2022) You won\u2019t feel high after watching this video. The Cut. Available at: https:\/\/www.thecut.com\/2022\/03\/you-wont-feel-high-after-watching-this-video.html (accessed 22 March 2022)."},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675512"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.12.040"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000436"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00962-y"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211069100"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120959604"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2019.1702544"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211055809"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881121991792"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-230109"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(17)30272-9"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2021.05.019"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198410000-00001"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030800"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1177\/0022167817715966"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01209-2"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1177\/13634615221082796."},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2021.1949454"},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8090331"},{"key":"e_1_3_3_117_1","first-page":"133","article-title":"At ease-subjective effects of MDMA in placebo-controlled studies with healthy subjects","volume":"88","author":"Vizeli P","year":"2019","unstructured":"Vizeli P, Holze F, Schmid Y, et al. (2019) At ease-subjective effects of MDMA in placebo-controlled studies with healthy subjects. Psychother Psychosom 88: 133\u2013134.","journal-title":"Psychother Psychosom"},{"key":"e_1_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881117691569"},{"key":"e_1_3_3_119_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1395197"},{"key":"e_1_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2019.1589028"},{"key":"e_1_3_3_121_1","doi-asserted-by":"publisher","DOI":"10.1177\/0022167817709585"},{"key":"e_1_3_3_122_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75706-1"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811221116926","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811221116926","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811221116926","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:11:07Z","timestamp":1777507867000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811221116926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":121,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1177\/02698811221116926"],"URL":"https:\/\/doi.org\/10.1177\/02698811221116926","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]}}}